Association of Hb F Level With Clinical Severity of Beta Thalassemia

Status Recruiting

Clinical Trial Summary

The production of Hb F after birth is an important factor in modifying the clinical severity of beta thalassemia because an increased gamma-globin level will bind the additional a-globin and form Hb F. The objective of this project is to evaluate the association of Hb F level with phenotypic diversity of patients with beta thalassemia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04917978
Study type	Observational
Source	Nanfang Hospital of Southern Medical University
Contact	Xiangmin Xu, Prof. Dr.
Phone	02061648293
Email	xixm@smu.edu.cn
Status	Recruiting
Phase
Start date	December 1, 2019
Completion date	December 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01049854` - CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant	Phase 2
Active, not recruiting	`NCT00408447` - Stem Cell Transplant in Sickle Cell Disease and Thalassemia	Phase 2
Completed	`NCT02597595` - Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major	N/A
Recruiting	`NCT06073860` - A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
Recruiting	`NCT05357482` - Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia	Phase 1/Phase 2
Completed	`NCT00790127` - Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia	Phase 1/Phase 2
Completed	`NCT00005934` - 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia	Phase 2
Completed	`NCT01931644` - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed	`NCT00159042` - Genetic Factors Affecting the Severity of Beta Thalassemia	N/A
Recruiting	`NCT04929574` - Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram
Recruiting	`NCT04918056` - Genetic Variants Affecting the Clinical Severity of Beta Thalassemia
Completed	`NCT00001958` - Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)	Phase 2